Clarfeld Financial Advisors’s AbbVie ABBV Stock Holding History

Clarfeld Financial Advisors’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	$76K	Buy	+816	New	+$71.8K	0.06%	81

Other funds holding ABBV

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

OAG

Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Clarfeld Financial Advisors's ABBV Position: Q4 2018 in Review

Clarfeld Financial Advisors opened a new position in AbbVie (ABBV) in Q4 2018: 816 shares worth $76K. The stake represents 0.06% of the portfolio and ranks #81 among its holdings.

2,063 funds tracked by Wall St. Rank hold ABBV as of Q4 2018.

Clarfeld Financial Advisors held 816 shares of AbbVie worth $76K as of Q4 2018.
AbbVie was a new Clarfeld Financial Advisors position in Q4 2018.
AbbVie made up 0.06% of Clarfeld Financial Advisors's portfolio in Q4 2018, its #81 holding.
2,063 funds tracked by Wall St. Rank held AbbVie as of Q4 2018.

Based on Clarfeld Financial Advisors's 13F filing for Q4 2018, filed 15 Feb 2019.